Abstract
The capacity of a cell to maintain proteostasis progressively declines during aging. Virtually all age-associated neurodegenerative disorders associated with aggregation of neurotoxic proteins are linked to defects in the cellular proteostasis network, including insufficient lysosomal hydrolysis. Here, we report that proteotoxicity in yeast and Drosophila models for Parkinson’s disease can be prevented by increasing the bioavailability of Ca2+, which adjusts intracellular Ca2+ handling and boosts lysosomal proteolysis. Heterologous expression of human α-synuclein (αSyn), a protein critically linked to Parkinson’s disease, selectively increases total cellular Ca2+ content, while the levels of manganese and iron remain unchanged. Disrupted Ca2+ homeostasis results in inhibition of the lysosomal protease cathepsin D and triggers premature cellular and organismal death. External administration of Ca2+ reduces αSyn oligomerization, stimulates cathepsin D activity and in consequence restores survival, which critically depends on the Ca2+/calmodulin-dependent phosphatase calcineurin. In flies, increasing the availability of Ca2+ discloses a neuroprotective role of αSyn upon manganese overload. In sum, we establish a molecular interplay between cathepsin D and calcineurin that can be activated by Ca2+ administration to counteract αSyn proteotoxicity.
Author summary
The accumulation and aggregation of neurotoxic proteins represents a hallmark of age-associated neurodegenerative disorders. Mostly, this is accompanied by a reduction of the cell’s capacity to proteolytically remove these aggregation-prone proteins. Thus, stimulation of degradative pathways to clear neurotoxic proteins represents an emerging theme to counteract neurodegeneration. The pathology of Parkinson’s disease (PD) is intimately connected to α-synuclein aggregation, and α-synuclein mutations or increased α-synuclein protein levels upon gene duplication cause hereditary PD. Using simple model systems to study α-synuclein toxicity, we establish a novel regime that re-activates cellular degradative capacity and prevents α-synuclein-induced cellular decline. Specifically, we show that increasing the bioavailability of Ca2+ stimulates protein degradation within the lysosome, the cell’s waste bin and recycling facility. Whereas α-synuclein compromised cellular Ca2+ homeostasis and reduced the activity of the lysosomal protease cathepsin D, simple administration of extra Ca2+ corrected these defects. We provide insights into the molecular pathways underlying cytoprotection achieved by Ca2+ supplementation and identify a causal role for central calcium signaling pathways in Ca2+-mediated stimulation of cathepsin D activity. In sum, our results establish a regime to improve the cellular capacity to cope with proteotoxic stress that functions across species barriers and might be transferable to other neurotoxic proteins.
Introduction
Parkinson’s disease (PD) is a progressive neurodegenerative disorder strongly associated with age and characterized by the selective degeneration and loss of dopaminergic neurons in the substantia nigra pars compacta [1,2]. Neuronal dysfunction during PD is coupled to the formation of intracellular protein inclusions termed Lewy bodies, mainly composed of α-synuclein (αSyn) [3]. The etiology of PD is assumed to be multifactorial, involving genetic susceptibility, aging and environmental risk factors such as heavy metals and pesticides as drivers of the disease [2]. The association between neurological damage and disrupted metal ion homeostasis has been established decades ago, and numerous epidemiological studies indicate that exposure to distinct metals, in particular iron, manganese, copper, and zinc, represents a clear risk factor for PD [4–7]. As transition metals serve as essential cofactors for a plethora of metalloproteins and thus impact biological processes at all levels, any perturbation of metal ion homeostasis will compromise cellular functionality. This is particularly evident in the brain, an organ that accumulates metal ions. Here, a disequilibrium of metal ions has been suggested to progressively disrupt Ca2+ homeostasis and in consequence essential neuronal functions that depend on tightly regulated cytosolic Ca2+ levels [8–10]. In line, the aggregation of αSyn as a main factor of both sporadic and familial PD [11–15], is intimately linked to metal ion homeostasis in general and to imbalances in Ca2+ homeostasis in particular: several metal ions, including Ca2+, have been shown to directly induce conformational changes of this intrinsically disordered protein and can accelerate aggregation and fibrillation of αSyn as well as cell-to-cell transmission [16–19]. Vice versa, αSyn impacts on metal ion homeostasis, in particular cellular calcium (Ca2+) handling and sequestration [20]. The interrelation between Ca2+ homeostasis and neuronal demise associated with αSyn remains enigmatic and seems highly dependent on the cellular context. Binding of Ca2+ to αSyn can induce the formation of αSyn oligomers both in vivo and in vitro [21–24], and αSyn has been shown to increase cellular influx and cytosolic levels of Ca2+, which in turn might amplify its oligomerization [25–29]. Furthermore, cleavage of αSyn by the Ca2+-activated protease calpain modulates its cytotoxicity [30,31]. Interestingly, binding of Ca2+ to αSyn has been proposed to regulate the physiological function of this protein chameleon that can adopt various structural conformations: although αSyn itself has only a moderate affinity for Ca2+, this seems physiologically relevant in cellular environments characterized by high Ca2+, such as pre-synaptic terminals. Here, binding of Ca2+ to the negatively charged C-terminus of αSyn has been shown to increase its lipid-binding capacity, enabling αSyn-mediated vesicle clustering and tethering of vesicles to the plasma membrane [21]. How αSyn causes a pathological increase of cytosolic Ca2+ is still under debate, but might involve increased membrane permeability, allowing influx of extracellular Ca2+ or altering intracellular storage capacity, or a direct interaction with organellar Ca2+ transporters, for instance the sarcoendoplasmic reticulum Ca2+ ATPase (SERCA) [32–35]. Similarly, it remains unclear how disrupted Ca2+ homeostasis connects to other pathological changes caused by excess or mutated αSyn, including for instance impaired proteostasis. Sub-optimal activity of different proteostatic subsystems, including autophagy and general lysosomal function, has been repeatedly linked to neurodegeneration associated with αSyn [36–39], and lysosomal Ca2+ has been suggested to impact the clearance of proteotoxic aggregates [40].
To further elucidate the connection between αSyn proteotoxicity and metal homeostasis in general as well as disrupted Ca2+ homeostasis in particular, we employed yeast and Drosophila expressing human αSyn, two genetically amenable model systems successfully used to unravel basic mechanisms of PD-associated cellular dysfunction [41–45]. We demonstrate that αSyn selectively increases total cellular Ca2+ content, while levels of other metals remain unchanged. Surprisingly, external administration of Ca2+ prevented αSyn proteotoxicity in yeast and Drosophila models. Mechanistically, external Ca2+ administration provided cytoprotection via stimulation of the lysosomal protease Cathepsin D and required functional calcineurin signaling. In sum, our data suggest that dietary Ca2+ supplementation impacts distinct aspects of the cellular proteostasis system, which concertedly counteract the proteotoxic consequences of αSyn.
Results
Administration of external Ca2+ protects against αSyn proteotoxicity
To analyze the link between disrupted metal homeostasis and αSyn proteotoxicity, we first assessed how αSyn would impact cellular metal content and, vice versa, how metal overload would affect αSyn toxicity employing a humanized budding yeast model. Most neurons are in a non-dividing, post-mitotic state. Thus, we used an experimental setup in which the xenotopic expression of human αSyn driven by a galactose promoter did not impact proliferation (Fig 1A) but instead triggered cellular dysfunction upon prolonged incubation in a post-mitotic state. Entry into the stationary phase (starting from ~20–24 h of culture time) coincided with a prominent increase of αSyn-induced cell death, as demonstrated by flow cytometric quantification of propidium iodide (PI) staining, indicative of lethal membrane integrity loss (Fig 1B). High levels of αSyn killed about 40% of the cell population within 36 h of incubation, while control cells displayed less than 10% dead cells (Fig 1B). Confocal microscopic analysis of the subcellular distribution and aggregation behavior of an αSyn-GFP chimera revealed no obvious differences between proliferating and post-mitotic cells (12 h versus 36 h). As reported previously [45], αSyn decorated the plasma membrane and appeared in small, membrane-attached as well as larger, cytoplasmic inclusions (Fig 1C). We used total reflection X-ray fluorescence (TXRF) spectrometry to quantitatively map the impact of αSyn on total cellular metal content after 24 h of cultivation. Interestingly, αSyn selectively increased total Ca2+ levels, while all other metals were unaffected (Fig 1D). Like mammalian cells, yeast cells ensure low resting cytosolic Ca2+ levels in the range of 50–200 nM through the action of an array of different Ca2+ channels and transporters facilitating organellar sequestration [46–48]. The prominent increase of total cellular Ca2+ levels in the presence of αSyn suggests enforced assimilation and subsequent sequestration into organellar Ca2+ stores, as efficient decoding of temporal Ca2+ signals necessitates a low resting cytosolic Ca2+ level [46].
Fig 1. Administration of external Ca2+ protects against αSyn proteotoxicity.
(A) Growth kinetics of wild type cells expressing human α-synuclein (αSyn) or harboring the corresponding vector control (Ctrl.) upon shift to galactose for promoter induction. Optical density (OD600nm) was determined every 30 min. Means ± s.e.m; n = 4. (B) Flow cytometric quantification of loss of membrane integrity via propidium iodide (PI) staining in cells expressing αSyn or harboring the vector control at indicated time points. Means ± s.e.m; n = 5. (C) Confocal micrographs of cells expressing GFP or αSynGFP for 12 h and 36 h. Cells were counterstained with PI to visualize dead cells. Z-projections of three-dimensional stacks as well as a representative section are shown. Scale bar represents 2 μm. (D) Total cellular metal content (Fe, Mn, Ca, Cu, Zn) of cells expressing αSyn for 24 h quantified via total reflection X-ray fluorescence (TXRF). Values were normalized to vector control cells per metal. Means ± s.e.m; n = 4. (E) Flow cytometric quantification of cell death via propidium iodide (PI) staining of cells expressing αSyn for 36 h or harboring the vector control. Growth medium was supplemented with indicated concentrations of K+, Fe2+, Mg2+, Mn2+, Ca2+, Cu2+ or Zn2+. Means ± s.e.m; n = 4. **p<0.01 and ***p<0.001.
As the overexposure to different metals is linked to αSyn-induced cellular dysfunction, we next assessed whether increased environmental levels of metal ions would impact on αSyn proteotoxicity. The concentrations of different metal ions used to study their effect on αSyn oligomerization, aggregation and cytotoxicity, both in vitro and in vivo, cover a rather broad range (from μM to mM) [19,49–52]. Aiming for intracellular overload of metal ions, we challenged cells with 500 μM—10 mM of several divalent cations and the monovalent cation K+ and quantified cell death after 36 h of αSyn expression and metal ion exposure. Though excess Fe2+, Zn2+ and in particular Cu2+ killed cells in a concentration-dependent manner, this was not specific for αSyn expression but reflected general metal ion poisoning per se (Fig 1E). Rather surprisingly, administration of Ca2+ prevented αSyn-induced cell death. This cytoprotection was dosage-dependent and Ca2+-specific, as Mg2+, another alkali earth metal with quite similar chemical and physical properties, had no effect (Fig 1E). Thus, though αSyn prominently disrupted Ca2+ homeostasis, causing cells to assimilate and sequester Ca2+ way beyond the physiological level, a further increase of Ca2+ availability in the surrounding still decreased αSyn toxicity. In model systems ranging from yeast, nematodes and flies to human cell culture and mice, αSyn toxicity has been linked to increased cytosolic Ca2+ levels [25,26,28,29], though molecular details remain unclear. Hence, any cytoprotective effect of Ca2+ administration seems rather counterintuitive.
An external Ca2+ pulse enforces organellar ion storage and mitigates the αSyn-driven increase of cytosolic Ca2+
As we found Ca2+-mediated cytoprotection to be dosage-dependent (Fig 1E), we tested whether a further increase of the external Ca2+ concentration would prevent toxicity even more efficiently. We added 10 mM or 50 mM Ca2+ to the culture media (normal concentration 1 mM) at the time point of galactose-driven induction of αSyn expression and assessed cell death at different time points after the diauxic shift (Fig 2A). Both concentrations delayed cell death with the same efficiency, indicating that maximal cytoprotective effects are already achieved (Fig 2A). Monitoring cell death throughout exponential growth and entry into stationary phase revealed that Ca2+ addition already efficiently counteracted the mild αSyn cytotoxicity visible in actively dividing cells (S1 Fig). As Ca2+ has been shown to influence the oligomerization and aggregation propensity of αSyn [21,24,53,54], we monitored αSyn-GFP aggregation upon exposure to Ca2+ and growth into stationary phase. Confocal microscopy revealed no change of the percentage of cells with large cytosolic αSyn aggregates (Fig 2B). However, semi-native immunoblotting demonstrated that Ca2+ administration resulted in decreased abundance of αSyn dimeric species (Fig 2C and 2D). As an increase in cytosolic Ca2+ has been shown to promote αSyn oligomerization, likely via direct binding of Ca2+ to the C-terminal part of αSyn [21], we next assessed the effect of external Ca2+ supplementation on cytosolic Ca2+ levels ([Ca2+]cyt) using yeast cells equipped with the Ca2+-dependent luminescent reporter protein aequorin. We observed a rapid and transient peak in [Ca2+]cyt as immediate cellular response to the addition of 10 mM and 50 mM Ca2+ at the time point of shift to galactose-media and thus prior to αSyn expression (Fig 2E). Cells rapidly restored basal [Ca2+]cyt, indicating efficient removal from the cytosol. As the time point of Ca2+ addition corresponded to the induction of αSyn expression, no effect of αSyn on [Ca2+]cyt was visible yet (Fig 2E). Following the basal [Ca2+]cyt throughout cellular growth into stationary phase, we found that the rapid and transient cytosolic Ca2+ spike seconds after Ca2+ addition had hardly any lasting effects on the resting [Ca2+]cyt in control cells (Fig 2F). As previously described [26], αSyn caused a progressive elevation of basal [Ca2+]cyt, with a maximal amplitude in mid-exponential phase. Notably, the early administration of extra Ca2+, concomitant with the induction of αSyn expression, partially correct these αSyn-driven consequences, diminishing the αSyn-induced rise in [Ca2+]cyt at all time points (Fig 2F). This drop in [Ca2+]cyt was likely due to enforced sequestration of cytosolic Ca2+ into organellar stores, as TXRF-based metal analysis revealed a further increase of total cellular Ca2+ content (Fig 2G).
Fig 2. An external Ca2+ pulse enforces organellar ion storage and mitigates the αSyn-driven rise in cytosolic Ca2+.
(A) Flow cytometric quantification of cell death via propidium iodide (PI) staining of cells expressing αSyn for indicated time points or harboring the vector control (Ctrl.). Cells were supplemented with additional 10 mM and 50 mM CaCl2 at the time point of shift to galactose or left untreated. Means ± s.e.m; n = 8. (B) Confocal micrographs of cells expressing αSynGFP for 24 h counterstained with PI to visualize dead cells. Cells were supplemented or not with 10 mM Ca2+ at the time point of shift to galactose media. Scale bar represents 5 μm. Values indicate mean percentages of cells with αSynGFP aggregates, with the following s.e.m.: Untreated: 28.1% ± 1.5% (in total 395 cells were evaluated); 10 mM Ca2+: 26.5% ± 1.8% (in total 643 cells were evaluated); n>4. (C-D) Representative semi-native immunoblots of protein extracts of cells grown on media with and without additional 10 mM Ca2+ for 36 h (C) and corresponding densitometric quantification (D) of dimeric αSyn species (as indicated by arrows in (C)). Blots were probed with antibodies directed against αSyn and tubulin as loading control, and the combined signal of the dimeric αSyn species was normalized to tubulin. Means ± s.e.m; n = 10. (E) Measurement of cytosolic Ca2+ levels in cells equipped with a luminescence-based aequorin reporter construct. After monitoring the basal cytosolic Ca2+ levels, Ca2+ was automatically injected to the indicated final concentrations to assess the rapid cellular response to the external Ca2+ addition. As measurements were performed at the time point of shift to galactose media, corresponding to the Ca2+ addition setup described in (A-D), αSyn is not yet expressed. Means ± s.e.m; n = 6. (F) Measurement of basal cytosolic Ca2+ levels in cells expressing αSyn or harboring the vector control and equipped with the aequorin reporter plasmid. 10 mM Ca2+ was added to the culture at the time point of galactose-induced expression and measurements were performed at indicated time points. Means ± s.e.m; n = 4. (G) TXRF-based quantification of total cellular Ca2+ levels in cells expressing αSyn for 12 h and 24 h supplemented or not with 10 mM Ca2+ at the time point of shift to galactose media. Values were normalized to untreated vector control cells at respective time points. Means ± s.e.m; n = 4. (H) Determination of calcineurin activity via flow cytometric quantification of GFP intensities in living (PI-negative) cells expressing destabilized GFP (GFPPEST) under the control of a calcineurin response element (CDRE). Cells expressing αSyn or harboring the vector control were grown in media with or without 10 mM CaCl2. Values have been normalized to t0 (prior to induction of αSyn expression). Means ± s.e.m; n = 12. (I) Transient [Ca2+]cyt responses measured as described in (E), but 10 mM Ca2+ was added to the culture 12 h after shift to galactose media for αSyn promoter induction. Means ± s.e.m; n = 6. (J) Determination of calcineurin activity as described in (H), but 10 mM Ca2+ was added to the culture 12 h after shift to galactose media for αSyn promoter induction. Values are depicted as fold of t0 as shown in (H). Means ± s.e.m; n = 12. (K) Flow cytometric quantification of cell death via PI-staining of cells expressing αSyn or harboring the vector control upon late addition of Ca2+. Cells grown on galactose media were analyzed prior to the addition of 10 mM Ca2+ (12 h) and at 24 h and 36 h. Means ± s.e.m; n = 4. *p<0.05, **p<0.01, and ***p<0.001.
The addition of extracellular Ca2+ and the subsequent rapid and transient rise in [Ca2+]cyt are known to activate calmodulin and in consequence its target calcineurin [55], a Ca2+-dependent protein phosphatase closely linked to neurodegeneration. Thus, we monitored calcineurin activity using the calcineurin-dependent response element (CDRE)-driven expression of GFP fused to a PEST-motif, marking it for rapid proteasomal degradation to circumvent accumulation. This setup allows the flow cytometric evaluation of calcineurin dynamics in vivo in unperturbed cells and the simultaneous exclusion of confounding dead cells via PI co-staining [56]. As expected, calcineurin activity mirrored [Ca2+]cyt kinetics (Fig 2H). Shortly after the external Ca2+ pulse, the immediate transient [Ca2+]cyt peak translated into a temporary increase in calcineurin activity, visible 1 h after Ca2+ addition (inset in Fig 2H). No further deviation from baseline calcineurin activity was detectable in control cells without αSyn expression throughout growth into stationary phase (Fig 2H). However, expression of αSyn resulted in a progressive activation of calcineurin, congruent with the elevation of [Ca2+]cyt (Fig 2F). Whereas the early administration of external Ca2+ confined the αSyn-induced rise in [Ca2+]cyt, this did not result in reduced calcineurin activation, indicating that already a persisting 2–3 fold increase of [Ca2+]cyt is sufficient to achieve maximal calcineurin activation (Fig 2F–2H). Once cells entered stationary phase, calcineurin activity decreased, concomitant with the drop in [Ca2+]cyt (Fig 2H).
Our findings suggest that an early external Ca2+ pulse, prior to the onset of αSyn-induced cellular stress, supports cellular Ca2+ handling to better cope with the toxic consequences of αSyn expression. To test whether the addition of Ca2+ to cells already expressing high levels of αSyn would still efficiently provide cytoprotection, we added 10 mM of Ca2+ after 12 h of αSyn expression, the time point of maximal [Ca2+]cyt amplitude. This still resulted in a rapid and transient spike of [Ca2+]cyt (Fig 2I) but had no prominent effect on calcineurin activity, which was already strongly increased due to αSyn expression (Fig 2J). Notably, this late external Ca2+ pulse still efficiently prevented cytotoxicity (Fig 2K). Collectively, these data indicate that the administration of external Ca2+, either prior to or during the expression of αSyn, triggers a cellular response that efficiently improves the cell’s capacity to cope with high levels of αSyn.
Cytoprotection achieved by Ca2+ administration requires functional calcineurin signaling
As αSyn resulted in a hyperactivation of calcineurin, we next analyzed the calmodulin/calcineurin system, the major and evolutionary conserved Ca2+ signaling pathway, for an involvement in αSyn cytotoxicity and in Ca2+-mediated cytoprotection. Within the complex protein network linking Ca2+ signaling and compartmentalization to cellular function in general and to diverse brain-specific processes in particular [57], calmodulin acts as a central intracellular receptor for Ca2+. Upon Ca2+ binding, calmodulin activates a variety of targets, among them the Ca2+/calmodulin-dependent protein kinases Cmk1 and Cmk2 and the protein phosphatase calcineurin (Fig 3A). Calcineurin consists of a catalytic (Cna1 or Cna2) and a regulatory (Cnb1) subunit, is activated via binding to the Ca2+/calmodulin complex and modulates the activity of an array of target proteins, including the calcineurin-responsive zinc finger transcription factor Crz1 [58,59]. To test whether genetic ablation of components of this Ca2+ signaling branch influences αSyn toxicity, we established αSyn expression in respective deletion mutants (Fig 3B) and monitored the kinetics of αSyn-induced cell death. Toxicity of αSyn was neither affected by the absence of the kinases Cmk1 and Cmk2 nor by the lack of either Cna1 or Cna2 alone, the two isoforms of the catalytic subunit of calcineurin (S2A and S2B Fig). Complete inactivation of calcineurin signaling, achieved either via simultaneous deletion of both CNA1 and CNA2 or via deletion of CNB1, increased αSyn toxicity to some extend but also resulted in slightly increased cell death per se (Fig 3C). Still, the absence of functional calcineurin accelerated αSyn-induced toxicity, resulting in sensitivity towards αSyn already at early time points (Fig 3C). Interestingly, the lack of the calcineurin-responsive transcription factor Crz1 had no impact on αSyn cytotoxicity (S2B Fig). The αSyn-driven rise in [Ca2+]cyt was further amplified by genetic inactivation of calcineurin (Fig 3D), and confocal microscopy revealed an increase in cells with large cytosolic αSyn aggregates (Fig 3E). In sum, this supports the notion that the absence of functional calcineurin enhances the deposition αSyn into large cytosolic aggregates and slightly expedites αSyn cytotoxicity, but has no major effect on αSyn-induced cell death.
Fig 3. Cytoprotection achieved by Ca2+ administration requires functional calcineurin signaling.
(A) Schematic of the main Ca2+ signaling pathway in yeast. Cytosolic Ca2+ binds to Calmodulin, which activates the Ca2+/calmodulin-dependent protein kinases Cmk1 and Cmk2 and protein phosphatase calcineurin. Calcineurin consists of a regulatory (Cnb1) and one of two catalytic subunits (Cna1 or Cna2) and dephosphorylates numerous cellular targets, among them the calcineurin-responsive zinc finger transcription factor Crz1, which in response translocates into the nucleus to adapt gene expression. Calcineurin can be inhibited by the immunosuppressant drug FK506. (B) Immunoblot analysis of protein extracts from WT cells and indicated deletion mutants after 24 h of αSyn expression. Blots were probed with antibodies directed against FLAG-epitope to detect FLAG-tagged αSyn and against glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as a loading control. (C) Cell death determined by propidium iodide (PI) staining of WT cells and calcineurin deletion mutants expressing αSyn or harboring the vector control (Ctrl.). Means ± s.e.m; n = 4. (D) Aequorin luminescence-based determination of basal cytosolic Ca2+ levels in WT and Δcnb1 cells expressing αSyn for 8 h and 12 h. Data were normalized to WT vector control. Means ± s.e.m; n = 12. (E) Confocal micrograph of WT and Δcnb1 cells expressing αSynGFP for 24 h. Cells have been counterstained with PI to visualize dead cells. Scale bar represents 5 μm. Values indicate mean percentages of cells with αSynGFP aggregates, with the following s.e.m.: WT: 28.1% ± 1.5% (in total 395 cells were evaluated); Δcnb1: 37.5% ± 3.2% (in total 299 cells were evaluated); n≥4. *p<0.05. (F) Cell death determined by PI staining of WT cells and indicated deletion mutants expressing αSyn for 36 h or harboring the vector control. Cells were supplemented or not with 10 mM Ca2+ at the time point of shift to galactose media. Means ± s.e.m; n = 4. (G) Clonogenic death of cells described in (F) grown for 36 h on galactose prior to determination of colony forming units on glucose full media agar plates. Death induced by αSyn was calculated via normalization to isogenic and similarly treated vector control. Means ± s.e.m; n = 8–16. (H) Flow cytometric quantification of cell death via PI staining of WT cells expressing αSyn for 36 h or harboring the vector control upon addition of 10 mM Ca2+ and 5 μM FK506. Means ± s.e.m; n = 8–12. (I) Flow cytometric quantification of cell death via PI staining of WT and Δcnb1 cells expressing αSyn or harboring the empty vector upon late addition of Ca2+. Cells grown on galactose media were analyzed prior to the addition of 10 mM Ca2+ (12 h) and at 36 h. Means ± s.e.m; n = 4. *p<0.05, and ***p<0.001.
Next, we tested for a causal role of this Ca2+ signaling branch in the suppression of αSyn proteotoxicity via Ca2+ supplementation. Inactivation of calcineurin signaling in Δcna1/2 and Δcnb1 cells inhibited Ca2+-mediated cytoprotection as determined via flow cytometric quantification of PI staining, while the administration of Ca2+ still efficiently reduced αSyn-induced cell death in all other mutants tested (Fig 3F). Determination of clonogenic death (i.e. the loss of colony forming capacity) confirmed an essential role for calcineurin in Ca2+-mediated cytoprotection (Fig 3G). This again was independent of the stress-induced transcriptional reprogramming via the calcineurin-dependent activation of Crz1, as the lack of this major transcription factor had no effect (Fig 3F and 3G). Pharmacological inhibition of calcineurin via the immunosuppressant drug FK506 further corroborated our findings: αSyn proteotoxicity could no longer be prevented by external administration of Ca2+ in a scenario where simultaneous addition of FK506 blocked calcineurin activity (Fig 3H). Moreover, the lack of Cnb1 diminished the efficiency of Ca2+-induced reduction of αSyn dimeric species (S2C and S2D Fig). Lastly, we also tested whether rescue via late Ca2+ addition to cells that already exhibit disrupted Ca2+ homeostasis due to prolonged αSyn expression would also require calcineurin. Again, functional calcineurin signaling was crucial for efficient cytoprotection (Fig 3I).
In sum, αSyn disrupts cellular Ca2+ handling and triggers a prominent increase in [Ca2+]cyt and a concurrent activation of calcineurin signaling. While the inactivation of calcineurin had only minor effects on αSyn proteotoxicity per se, it precluded cytoprotection achieved by Ca2+ supplementation. Crz1, which coordinates calcineurin-dependent transcriptional reprogramming, was not involved, suggesting that alternative calcineurin targets might contribute to Ca2+ -mediated protection.
Organellar Ca2+-sequestration differentially contributes to Ca2+-mediated cytoprotection
To further identify molecular determinants and processes involved in the cellular response to Ca2+ supplementation and the mitigation of αSyn proteotoxicity, we screened 41 yeast deletion mutants connected to calcineurin signaling and Ca2+ homeostasis (Fig 4A). This included mutants lacking previously identified direct substrates of calcineurin, among them proteins involved in membrane structure and function, ubiquitin signaling, transcription and translation, protein transport and Ca2+ signaling [60]. Moreover, as the vacuole serves as main Ca2+ reservoir in yeast, we additionally assessed mutants devoid of proteins involved in vacuolar Ca2+ transport and function. In most strains, the inhibition of αSyn-induced cell death by Ca2+ administration was efficiently maintained (Fig 4A). However, the beneficial effects of Ca2+ were compromised in cells lacking the calcineurin targets Hph1 and Hph2, two homologous ER-proteins involved in stress response and necessary for proper biogenesis and assembly of the vacuolar H+-ATPase governing vacuolar acidification [61]. Furthermore, depleting vacuolar Ca2+ via simultaneous inactivation of the two main vacuolar Ca2+ transporters Pmc1 and Vcx1 as well as lack of Pep4, the yeast orthologue of mammalian Cathepsin D (CatD) and major vacuolar protease, hampered Ca2+-mediated cytoprotection. In addition, Spt8, a subunit of the Spt-Ada-Gcn5 acetyltransferase (SAGA) complex and a calcineurin substrate, was required for Ca2+-mediated cytoprotection. Interestingly, the SAGA subunit Spt7 has been shown to be cleaved by Pep4, which results in the loss of Spt8 from the SAGA complex and the formation of a SAGA-like (SLIK) complex [62,63]. Altogether, these data clearly point to a crucial role of vacuolar function in Ca2+-mediated mitigation of αSyn proteotoxicity.
Fig 4. Organellar Ca2+-sequestration differentially contributes to Ca2+-mediated cytoprotection.
(A) Cell death determined by propidium iodide (PI) staining of WT cells and indicated deletion mutants, expressing αSyn for 36 h. Untreated cells were compared to cells treated with 10 mM Ca2+, and the cell death ratio (αSyn+Ca2+ / αSyn) was plotted. Strains above a threshold of 0.6 are depicted in bright red (if different to WT ratio with p<0.05) or in dark red (if not significant). Means ± s.e.m; n = 4–8. (B-G) Measurement of basal cytosolic Ca2+ levels in WT cells and Δcnb1 mutants (B-D) or Δpmc1Δvcx1 mutants (E-G) equipped with the aequorin reporter plasmid and expressing αSyn or harboring the vector control (Ctrl.). Rapid transient [Ca2+]cyt responses within 80 s upon early (B, E) or late (D, G) addition of 10 mM Ca2+ to cells expressing αSyn for 0 h (B, E) or 12 h (D, G) were quantified. In addition, resting cytosolic Ca2+ levels (C, F) were determined 12 h after cells expressing αSyn have been treated with 10 mM Ca2+. Means ± s.e.m; n = 6–8. (H, I) Immunoblot analysis of protein extracts from WT, Δpmc1Δvcx1 and Δpmr1 cells expressing αSyn for 24 h or harboring the vector control. Blots were probed with antibodies directed against FLAG-tagged αSyn and against glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as a loading control. (J) Cell death determined by PI staining of WT and Δpmr1 cells expressing αSyn for 36 h or harboring the vector control. Cells were grown for 36 h in galactose media with or without the addition of 10 mM Ca2+ at the time point of shift to galactose media. Means ± s.e.m; n = 4. (K) Representative semi-native immunoblot of protein extracts of WT and Δpmr1 cells grown on media with and without additional 10 mM Ca2+ for 36 h. Blots were probed with antibodies directed against tubulin as loading control and against αSyn (short and long exposure is shown), and dimeric αSyn species are indicated by arrows. (L) TXRF-based quantification of total cellular Ca2+ content measured in WT cells and indicated deletion mutants expressing αSyn or harboring the vector control. Cells were grown for 24 h in galactose media with or without addition of 10 mM Ca2+ at the time point of shift to galactose media. Data was normalized to untreated WT control. Means ± s.e.m; n = 4. *p<0.05, **p<0.01, and ***p<0.001.
To further assess the contribution of cellular and in particular vacuolar Ca2+ handling to αSyn proteotoxicity and Ca2+-mediated cytoprotection, we analyzed cytosolic Ca2+ levels in Δcnb1 (Fig 4B–4D) and in Δpmc1Δvcx1 mutants (Fig 4E–4G). We monitored (i) the rapid peak of [Ca2+]cyt immediately after early Ca2+ addition, (ii) basal [Ca2+]cyt after prolonged αSyn expression and Ca2+ treatment for 12 h, and (iii) the rapid [Ca2+]cyt response upon late Ca2+ addition. The loss of calcineurin signaling had no prominent effect on the rapid, transient [Ca2+]cyt peak immediately after the early or late Ca2+ addition, and restoration of resting [Ca2+]cyt was quite comparable to wild type cells (Fig 4B–4D). However, Ca2+ administration no longer mitigated the increase of basal [Ca2+]cyt driven by αSyn in absence of functional calcineurin (Fig 4C). In cells lacking Pmc1 and Vcx1, [Ca2+]cyt levels were strongly elevated in particular upon late addition of Ca2+ to cells expressing αSyn (Fig 4G), likely because the removal of Ca2+ from the cytosol into the vacuole upon supplementation of Ca2+ was compromised. Overall expression levels of αSyn were not affected (Fig 4H). In addition to the vacuole, the ER and Golgi represent important lumenal stores for cellular Ca2+. Transport of Ca2+ into these secretory compartments mainly depends on the action of the phylogenetically conserved Ca2+/Mn2+ ATPase Pmr1, the yeast ortholog of mammalian SPCA. The loss of Pmr1 results in decreased Ca2+ in the ER and Golgi while increasing vacuolar Ca2+ sequestration [64,65] and suppresses αSyn toxicity in several PD model systems [26]. To test whether loss of Ca2+ sequestration into the ER and Golgi in absence of Pmr1 would affect Ca2+-mediated cytoprotection, we expressed αSyn in Δpmr1 cells (Fig 4I) and administered extra Ca2+. Notably, Ca2+ addition completely prevented αSyn-induced cell death in cells lacking Pmr1, restoring cellular viability back to wild type control cells (Fig 4J). Semi-native immunoblotting demonstrated a decrease in αSyn dimeric species in Δpmr1 cells and a slight accumulation of high-molecular weight species. Supplementation with Ca2+ resulted in the disappearance of these larger species and further reduced dimeric αSyn species (Fig 4K). TXRF-based metal analysis revealed that Ca2+-mediated cytoprotection and the change in αSyn oligomerization was accompanied by a massive increase of total cellular Ca2+ (Fig 4L). As sequestration into the secretory pathway is compromised in cells devoid of Pmr1, this most probably depicts increased Ca2+ storage within the vacuole. In line, the boost of total cellular Ca2+ load upon Ca2+ administration was reduced in cells deficient in vacuolar Ca2+ sequestration due to lack of Pmc1 and Vcx1 (Fig 4L). This supports the notion that increasing vacuolar Ca2+ storage capacity is beneficial to maintain cellular fitness despite high levels of αSyn.
In aggregate, these findings suggest that an external Ca2+ pulse triggers a cellular response that mitigates the αSyn-driven rise in [Ca2+]cyt in a calcineurin-dependent way and leads to the sequestration of excess Ca2+ into the vacuole via cooperative action of the vacuolar transporters Pmc1 and Vcx1. Moreover, combining genetic inactivation of Pmr1, which prevents sequestration of Ca2+ into the secretory pathway and potentiates its transport into the vacuole, with external Ca2+ addition reduces αSyn oligomerization and completely prevents αSyn proteotoxicity.
Ca2+-addition triggers calcineurin-dependent hyperactivation of Pep4
Besides calcineurin signaling and vacuolar Ca2+ transport, we also identified the vacuolar protease Pep4, yeast CatD, as crucial for Ca2+-mediated cytoprotection. The lack of Pep4 completely precluded the beneficial effects of Ca2+ addition on cellular survival (Fig 5A). Moreover, functional Pep4 was required for efficient Ca2+-induced reduction of αSyn dimeric species (Fig 5B and 5C). Vice versa, overexpression of Pep4 decreased αSyn protein abundance and reduced αSyn proteotoxicity (Fig 5D and 5E), in line with our previous results [66]. A combination of high levels of Pep4 and simultaneous Ca2+ supplementation inhibited cell death even more efficiently, arguing for additive cytoprotection conferred by these two interventions (Fig 5E). Biochemical quantification of Pep4 activity revealed a prominent reduction of proteolytic capacity upon αSyn expression, which could be restored by Ca2+ administration (Fig 5F). Remarkably, the administration of Ca2+ not only completely blocked the αSyn-driven reduction of Pep4 activity, but even overcompensated, leading to hyperactivity of this protease in all cells independent of αSyn expression (Fig 5F). As we have recently established a link between calcineurin signaling and efficient trafficking of Pep4 to the vacuole [66], we tested whether calcineurin would be required for the Ca2+-mediated boost of vacuolar proteolysis. Indeed, the lack of Cnb1 not only reduced Pep4 activity per se, but also completely prevented the activation of Pep4 by Ca2+ administration (Fig 5F). Thus, Ca2+-administration triggers a calcineurin-dependent hyperactivation of Pep4, which in consequence improves survival of cells expressing αSyn.
Fig 5. Ca2+-addition triggers calcineurin-dependent hyperactivation of Pep4.
(A) Cell death determined by propidium iodide (PI) staining of WT and Δpep4 cells, expressing αSyn for 36 h or harboring the vector control (Ctrl.) with or without addition of 10 mM Ca2+. Means ± s.e.m; n = 4. (B, C) Representative semi-native immunoblots of protein extracts of cells grown on media with and without additional 10 mM Ca2+ for 36 h (B) and corresponding densitometric quantification (C) of dimeric αSyn species (as indicated by arrows in (B)). Blots were probed with antibodies directed against αSyn and tubulin as loading control, and the combined signal of the dimeric αSyn species was normalized to tubulin. Means ± s.e.m; n = 5. (D) Immunoblot analysis of protein extracts from cells expressing αSyn and additionally overexpressing Pep4 (Pep4 oex.) under the control of a galactose promoter. Blots were probed with antibodies against FLAG-tagged αSyn and Pep4, as well as GAPDH as loading control. (E) Cell death determined by PI staining of cells described in (D). Cells were treated with 10 mM Ca2+ at the time point of induction of galactose-driven expression of αSyn and Pep4 (Pep4 oex.). Means ± s.e.m; n = 4. (F) Biochemical measurement of Pep4 proteolytic activity in WT or Δcnb1 cells expressing αSyn for 16 h or harboring the vector control with or without addition of 10 mM Ca2+. Means ± s.e.m; n = 4. *p<0.05, **p<0.01, ***p<0.001, and n.s. not significant.
Administration of Ca2+ activates CatD in Drosophila and prevents αSyn proteotoxicity
Finally, we tested for phylogenetic conservation of the cytoprotective effects of Ca2+ administration. To this end, we used a Drosophila model for PD based on the pan-neuronal expression of human αSyn under the control of the UAS-GAL4 system. We combined this genetic trigger for PD with manganese treatment, an environmental risk factor for PD [44]. This setup was reported to cause the death of flies within days [26,41]. To increase Ca2+ intake, we supplemented the food with additional 15 mM Ca2+ for 1 week prior to exposure to manganese. The xenotopic expression of αSyn selectively in the fly brain accelerated manganese toxicity, leading to significantly decreased survival compared to control flies (Fig 6A–6C). However, pre-feeding of these flies with extra Ca2+ for 1 week prior to manganese exposure prevented αSyn-driven organismal death. Of note, Ca2+ pre-feeding not only precluded αSyn toxicity but also efficiently counteracted the toxic consequences of manganese overload per se (Fig 6A and 6B). Next, we explored a role for Drosophila CatD in the pro-survival effect of Ca2+ feeding. The neuronal expression of αSyn clearly compromised CatD function, as indicated by biochemical quantification of CatD activity in fly head lysates after 1 week of manganese exposure (Fig 6D). This defect was absent in flies pre-fed with extra 15 mM Ca2+ prior to manganese stress (Fig 6D). Remarkably, extending the Ca2+ pre-feeding period blocked αSyn toxicity completely. In fact, when keeping flies on food supplemented with extra Ca2+ for 2 weeks prior to exposure to manganese, the neuronal expression of αSyn even provided cytoprotection (Fig 6E and 6F). Thus, depending on the environmental availability of Ca2+, αSyn either expedites or counteracts manganese-induced neurotoxicity. Similarly, toxic versus protective effects of αSyn were apparent when monitoring motor function (Fig 6G). Neuronal expression of αSyn clearly compromised climbing ability, measured as capacity of negative geotaxis, upon exposure to manganese. However, when flies were pre-fed with Ca2+ for 2 weeks, αSyn no longer compromised but instead improved motor function (Fig 6G). These data suggest a beneficial function of αSyn in neurons upon manganese overload that is highly dependent on Ca2+ availability.
Fig 6. Administration of Ca2+ activates Cathepsin D in Drosophila and prevents αSyn proteotoxicity.
(A-B) Survival of flies neuronally expressing human αSyn (UAS-αSyn) driven by nsyB-Gal4 and corresponding control flies upon exposure to 10 mM Mn2+. 1–3 days old female flies were collected and kept on food with or without additional 15 mM Ca2+ for 1 week prior to Mn2+ exposure. Kaplan-Meier survival analysis (A) and corresponding mean survival (B) is shown. In total, 470–560 flies per genotype and condition were evaluated, and 30 flies were kept per vial. (Genotypes: Ctrl. = Nsyb-Gal4>w1118; αSyn = Nsyb-Gal4>UAS-αSyn). (C) Immunoblot analysis of head lysates from flies described in (A). Blots were probed with antibodies directed against αSyn and tubulin (αTub) as loading control. (D) Biochemical measurement of cathepsin D (CatD) proteolytic activity in head lysates of flies described in (A). Prior to Mn2+ stress, flies were kept on food with or without additional 15 mM Ca2+ for 1 week. Heads were collected after 7 days of Mn2+ treatment. Means ± s.e.m; n = 6–7. (E-F) Survival of flies neuronally expressing αSyn (UAS-αSyn) driven by nsyB-Gal4 and corresponding control flies upon exposure to 10 mM Mn2+. 1–3 days old female flies were collected and kept on food with or without additional 15 mM Ca2+ or 30 mM Ca2+ for 2 weeks prior to Mn2+ exposure. Kaplan-Meier survival analysis (E) and corresponding mean survival (F) is shown. In total, 340–400 flies per genotype and condition were evaluated, and 30 flies were kept per vial. (G) Climbing activity of flies described in (E) after 6 days of Mn2+ treatment. Means ± s.e.m; n = 6 with 6–8 flies per vial. (H) Biochemical measurement of CatD proteolytic activity in head lysates of flies neuronally expressing αSyn (UAS-αSyn) driven by nsyB-Gal4 and corresponding control flies. Heads were collected at day 1 (on standard food without additional Ca2+ or Mg2+ supplementation) and after 14 days, during which flies were kept on food supplemented with either 15 mM Ca2+, 15 mM Mg2+ or without supplementation as indicated. Means ± s.e.m; n = 4. *p<0.05, **p<0.01, ***p<0.001, and n.s. not significant.
Finally, we tested for an effect of αSyn on CatD activity in absence of manganese as additional toxic trigger and thus conditions where neuronal αSyn expression did not yet affect Drosophila survival. Indeed, in flies aged for 2 weeks on regular food, the neuronal expression of αSyn already prominently reduced CatD proteolysis (Fig 6H). Supplementation of food with 15 mM Ca2+ (but not with 15 mM Mg2+) completely prevented these pathological changes (Fig 6H). Hence, increasing Ca2+ availability precludes αSyn-induced lysosomal dysfunction, efficiently prevents αSyn toxicity upon manganese overload and discloses a cytoprotective function of αSyn within Drosophila neurons.
Discussion
Defects in the lysosomal pathway are intimately linked to the pathogenesis of neurodegenerative disorders associated with proteotoxic stress, such as PD [36,38,39]. In this study, we establish a novel regime to re-activate lysosomal degradative capacity and provide insights into the underlying molecular circuits. We demonstrate that administration of Ca2+ prevents αSyn proteotoxicity in yeast and Drosophila models for PD and link this cytoprotection to the activation of lysosomal CatD proteolysis. While αSyn prominently decreased CatD activity in yeast cells and fly brains, extra Ca2+ completely restored this defect, thus efficiently equipping the lysosome for proteolytic breakdown. This compensates for the proteostatic stress posed by high αSyn levels and improves cellular and organismal viability.
Conceptually, cytoprotection mediated by Ca2+ supplementation seems to involve different, likely interrelated processes. On the one hand, Ca2+ addition drives a cellular response that adjusts cell physiology and Ca2+ handling to better cope with the toxic effects of αSyn. On the other hand, it affects αSyn itself and alters its oligomerization propensity, thereby mitigating its toxic effects on Ca2+ homeostasis and lysosomal function (Fig 7). αSyn causes a massive increase in cytosolic Ca2+, which, in turn, can induce αSyn oligomerization [21,22], likely representing a self-amplifying loop. The administration of Ca2+ results in a rapid but transient rise of cytosolic Ca2+, followed by efficient sequestration into organellar stores to restore resting cytosolic Ca2+ levels. The sustained increased availability of Ca2+ in the environment provokes an adjustment of cellular Ca2+ handling that requires calcineurin signaling and efficient sequestration of cytosolic Ca2+ into the vacuole. This, in turn, attenuates the αSyn-induced elevation of resting cytosolic Ca2+ levels, which in consequence may be responsible for the reduced abundance of αSyn oligomers, assumed to be the primary toxic αSyn species.
Fig 7. Schematic overview of αSyn proteotoxicity and the calcineurin-dependent stimulation of vacuolar proteolysis upon Ca2+ supplementation.
Upon heterologous expression of human αSyn, oligomers and large cytosolic aggregates form and cytosolic Ca2+ levels increase, which might in turn further accelerate αSyn oligomerization. αSyn impairs Pep4/CatD proteolytic activity, most probably via interference with calcineurin-dependent recycling of the shuttling receptor of Pep4/CatD. In turn, decreased vacuolar/lysosomal proteolytic capacity leads to cell death (left panel). Supplementation with Ca2+ reduces αSyn oligomerization, mitigates the αSyn-driven rise in cytosolic Ca2+ via sequestration into organellar stores, in particular the vacuole, and stimulates calcineurin-dependent shuttling of Pep4/CatD and thus vacuolar proteolytic capacity. Collectively, this decreases αSyn proteotoxicity and supports viability. Loss of Ca2+ transport into the secretory pathway via genetic inactivation of Pmr1 even increases the cytoprotective capacity of Ca2+ supplementation.
In addition, we find that organellar Ca2+ sequestration differentially contributes to Ca2+-mediated cytoprotection. In yeast, Ca2+ mainly accumulates within the vacuole or is sequestered into the secretory pathway, while mitochondria lack selective Ca2+ channels and seem to play a minor role in Ca2+ storage [67–69]. Our results suggest that Ca2+ sequestration into the vacuole is necessary for efficient Ca2+-mediated rescue, while transport into the secretory pathway is dispensable. In fact, inactivation of the secretory pathway Ca2+/Mn2+ ATPase Pmr1 even supported the beneficial effects of Ca2+ administration, resulting in a reduction of αSyn oligomeric species and a complete absence of αSyn proteotoxicity. We have previously shown that cytosolic Ca2+ overload and subsequent cellular demise driven by high levels of αSyn requires the Ca2+-transporting activity of Pmr1, a pump causal for αSyn toxicity in yeast, nematode and fly models for PD [26]. Vice versa, overexpression of Pmr1 massively aggravated cell death induced by αSyn [26]. Supporting the notion that inactivation of Ca2+ transport into the secretory pathway alleviates αSyn toxicity, the pharmacological inhibition of the C. elegans sarco/endoplasmic reticulum Ca2+ ATPase SERCA via cyclopiazonic acid prevented αSyn-induced dopaminergic neuron loss. Moreover, treatment with cyclopiazonic acid restored normal cytosolic Ca2+ levels in a primary neuronal αSyn model [33]. In line with this, our data indicate that Δpmr1 cells, harboring a reduced potential to sequester Ca2+ into the secretory pathway but instead strongly accumulating Ca2+ in the vacuole [64,65,70], are less susceptible to the toxic effects of αSyn expression. Moreover, these cells are completely resistant to αSyn toxicity when additionally supplied with high external Ca2+. Supplementation with Ca2+ not only mitigated the αSyn-driven elevation of cytosolic Ca2+ but also massively increased total cellular Ca2+ content, reflecting uptake into the vacuole as main organellar Ca2+ depot. Reminiscent of recent findings demonstrating that increased vacuolar Ca2+ sequestration via overexpression of Pmc1 can reduce αSyn-induced growth arrest [27], lack of the vacuolar Ca2+ transporters Pmc1 and Vcx1, reported to decrease vacuolar Ca2+ storage [64,71], precluded efficient cytoprotection via Ca2+ supplementation, suggesting a causal contribution of the vacuole. Moreover, increased vacuolar Ca2+ sequestration coincided with a stimulation of CatD activity that strictly required functional calcineurin signaling and was critical for cytoprotection. Administration of Ca2+ no longer prevented αSyn proteotoxicity in cells lacking CatD, demonstrating a key role for calcineurin-dependent stimulation of this vacuolar aspartyl protease in Ca2+-mediated cytoprotection. In different PD model systems, high levels of αSyn have been shown to impair CatD activity, and, vice versa, the overexpression of CatD reduced αSyn toxicity as well as the abundance of αSyn oligomers and aggregates [66,72–74]. Compromised CatD proteolysis was caused by defective function of its sorting receptor, the mannose 6-phosphate receptor, which mislocalized to the lysosomal membrane instead of shuttling between the trans-Golgi and the lysosome in successive rounds of transport [66,72]. We have recently demonstrated that functional calcineurin signaling is required for efficient trafficking and recycling of Pep1, the yeast mannose-6-phosphate receptor, and thus delivery of yeast CatD to the vacuole and the cytoprotective effects of CatD overexpression [66]. In line, we now show that genetic inactivation of calcineurin not only compromises CatD activity per se but also completely abrogates the boost of CatD activity achieved by Ca2+ supplementation. Moreover, efficient Ca2+-mediated reduction of αSyn dimeric species involved both calcineurin and CatD. As shown previously, calcineurin is critical for the efficient retrieval of Pep1 from the vacuole back to the trans-Golgi network [66], a process mediated by the retromer complex. Malfunction of this highly conserved multimeric complex via point mutation of its component Vps35 has been linked to different forms of PD [75] and results in insufficient CatD activity and lysosomal dysfunction in different PD model systems [76–79]. Still, whether calcineurin contributes to efficient retromer-mediated recycling of Pep1 and thus CatD trafficking remains to be tested. Alternatively, calcineurin might contribute to Ca2+ signaling-mediated dephosphorylation of Ykt6, a SNARE with critical roles in CatD trafficking and Golgi membrane fusion implicated in αSyn toxicity [80–82].
The involvement of calcineurin in neurodegeneration seems rather complex, as both excessive and insufficient activity are associated with neuronal dysfunction [83–87]. In several PD models, an intermediate activity of calcineurin prevented αSyn toxicity, while complete loss and hyperactivation amplified proteotoxicity [34]. A direct interaction between αSyn and calcineurin has been demonstrated in vitro [88], but whether such an interaction contributes to observed phenotypes is subject to speculation. While the regulatory circuits determining cytocidal versus cytoprotective effects remain yet elusive, the fine-tuning of calcineurin activity seems to determine the cellular response to αSyn [34,66]. We find calcineurin to impact on αSyn proteotoxicity and to support Ca2+-mediated rescue at different levels. Though the prominent rise of cytosolic Ca2+ levels upon αSyn expression translated into a hyperactivation of calcineurin, the absence of calcineurin had only minor effects on αSyn toxicity per se, although it increased the abundance of large αSyn aggregates. However, upon Ca2+ supplementation, calcineurin was critical to equip the vacuole with CatD and to restore lysosomal proteolysis, likely by supporting the trafficking of CatD via the mannose-6-phosphate receptor Pep1. In addition, calcineurin enabled the cell to efficiently cope with αSyn-induced disturbances of Ca2+ homeostasis, thereby diminishing the αSyn-driven elevation of cytosolic Ca2+ levels. As such, at least basal activity of calcineurin is required to achieve cytoprotection by Ca2+.
Interestingly, in particular dopaminergic neurons seem sensitive to perturbations in Ca2+ homeostasis [89–91]. In contrast to the vast majority of neurons in the brain, adult dopaminergic neurons strongly rely on specific voltage-dependent Ca2+ channels to drive rhythmic pace-making [90,92]. With progressing age, this causes a sustained increase in cytosolic Ca2+ levels, critically contributing to the highly cell-type specific decay of dopaminergic neurons during PD [90,93]. Moreover, voltage-gated Ca2+ entry seems intimately connected to PD pathology in general and αSyn toxicity in particular [21,35,94,95]. Still, despite clear evidence that high cytosolic Ca2+ and αSyn in combination drive PD-associated neuronal degeneration, the voltage-gated Ca2+ channel blocker isradipine did not slow the progression of early-stage PD in clinical trials [96], and observational studies in respect to serum Ca2+ levels in PD patients are inconclusive [97].
Adding to a highly complex connection between Ca2+ homeostasis and αSyn, cellular Ca2+ handling does not only impact the toxicity of αSyn but also its physiological role in vesicle clustering in the pre-synaptic terminal [21]. In line with Ca2+ as a critical regulator of the physiological function of αSyn in neurons, we demonstrate that Ca2+ bioavailability determines toxic versus beneficial effects of αSyn when xenotopically expressed in Drosophila neurons. While pan-neuronal expression of αSyn resulted in increased death of flies exposed to manganese, pre-feeding with extra Ca2+ prior to manganese treatment not only prevented toxicity but disclosed a neuroprotective function of αSyn. When kept on food supplemented with extra Ca2+, neuronal expression of αSyn prevented manganese-induced motor dysfunction and extended Drosophila survival. Interestingly, in neuronal cell culture, physiological levels of αSyn have already been suggested to prevent manganese-induced neurotoxicity [98], and lack of αSyn aggravated motor deficits in mice exposed to manganese [99]. In addition, expression of αSyn has been suggested to prevent acute manganese toxicity in C. elegans devoid of orthologs of additional PD-associated genes implicated in oxidative stress pathways [100]. Thus, depending on the respective genetic setup, αSyn can either enhance or reduce manganese-induced cellular decline, and this seems highly depended on Ca2+ availability.
Collectively, our results suggest an evolutionary conserved mechanism by which early and late Ca2+ administration adjusts cellular Ca2+ handling and stimulates lysosomal proteolytic activity in a calcineurin-dependent manner, resulting in a reduction of αSyn proteotoxicity. Whether this will be transferable to other neurotoxic proteins remains to be investigated. However, in light of the highly conserved fundamental processes compromised by αSyn and corrected by Ca2+ administration, this regime may improve the cell’s capacity to cope with proteotoxic stress in general.
Material and methods
S. cerevisiae strains and genetics
Experiments were carried out in BY4741 (MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0) and respective null mutants. Notably, phenotypes observed in null mutants obtained from Euroscarf were confirmed with handmade deletion mutants. All strains used in this study are listed in S1 Table. Yeast plasmid transformation was performed using a standard lithium acetate method [101]. Previously described αSyn-constructs in pESC-His and pESC-Ura (Stratagene) were used, coding for C-terminally FLAG-tagged (in pESC-his) or C-terminally GFP-tagged (in pESC-Ura) versions of human αSyn under the control of a GAL10 promoter [41,66,102]. For co-expression of αSyn and Pep4, recently described constructs in pESC-Ura for αSyn and pESC-His for Pep4 were used [66]. Generation of deletion mutants of interest was performed according to Janke et al. using the pFA6a-hphNTI plasmid to generate knockout cassettes containing a hygromycin B selection marker [103]. All primers used are listed in S2 Table.
Yeast culture conditions and analysis of viability
All strains were grown on synthetic complete (SC) medium containing 0.17% yeast nitrogen base (Difco), 0.5% (NH4)2SO4 and 30 mg/l of all amino acids (except 80 mg/l histidine and 200 mg/l leucine), 30 mg/l adenine, and 320 mg/l uracil with either 2% glucose (SCD) or 2% galactose (SCG) for induction of GAL10-driven expression of αSyn. To determine growth, survival, oxidative stress and loss of membrane integrity, cells from SCD overnight cultures were inoculated in fresh SCD to OD600 0.1, grown to midlog phase (OD600 0.3–0.35) and shifted to SCG for induction of αSyn expression. Immediately after the shift to SCG, cells were treated with indicated concentrations of metals using stocks of 1 M NaCl, 1 M Mg2SO4, 1 M KCl, 1 M CaCl2, 1 M MnCl2, 0.5 M Fe2SO4, 1 M Cu(NO3)2 and 1 M ZnCl2 in ddH2O. For ‘late addition’ of Ca2+, cells were treated with 10 mM CaCl2 at 12 h after shift to SCG. For pharmacological inhibition of calcineurin activity, media was supplemented with 5 μM FK506 (Sigma; stock 2.5 mM in DMSO). For clonogenic survival plating, aliquots were taken at indicated time points and colony-forming units (CFU) were determined as previously described [26,104]. Briefly, a CASY cell counter (Schärfe systems) was used to measure the cell counts, 500 cells were plated on full media (YEPD) agar plates and CFU were quantified after two days of growth using a Scan300 (Interscience). To measure loss of membrane integrity, cultures were subjected to propidium iodide (PI)-staining after indicated time of αSyn expression. To this end, about 2x106 cells were collected in 96 well plates via centrifugation, resuspended in 250 μl of 100 ng/ml PI in PBS and incubated for 10 min in the dark. Cells were pelleted, washed once in PBS and subjected to quantification via fluorescence reader (TECAN GeniosPro) or flow cytometry (BD LSR Fortessa/ Guava easyCyte 5HT). For quantifications using flow cytometry, at least 3000 cells were evaluated and analyzed with BD FACSDiva/ InCyte (3.1) software. To determine growth, cells were shifted to SCG at OD600 0.3, transferred to Honeycomb microplates and analyzed using a Bioscreen C (Oy Growth Curves Ab Ltd). Plates were kept shaking at medium speed at 28°C, cell density was determined every 30 min for 24 h and shaking was interrupted 5 sec prior to each measurement. Notably, for all experiments, at least four different clones were tested after gene deletion via homologous recombination and plasmid transformation to rule out clonogenic variations.
Drosophila stocks, husbandry and climbing activity
All Drosophila lines were kept at 25°C, 60% humidity and a 12 h light/dark cycle on standard potato sucrose food (per liter: 12.9 g dry yeast, 500 ml syrup, 40 g instant mashed potato powder, 10 g agar, 8.5 ml Nipagin and 1 g ascorbic acid). Wild type w1118 flies (3605) as well as the UAS-αSyn line (8146) were obtained from Bloomington stock center (Indiana University, USA) and the nsyb-GAL4 driver line (gift from Stephan Sigrist) was used for pan-neuronal expression. All lines were isogenized against w1118 for at least 6 generations. Crossings were performed using a female to male ratio of about 3:1. The genotypes Nsyb-Gal4>w1118 and Nsyb-Gal4>UAS-αSyn were used for all experiments, and 1–3 days old flies were collected, sex-sorted using CO2 anesthesia and females were transferred onto fresh food in cohorts of 30 flies per vial. Flies were kept at 29°C for 24 h to enhance GAL4-driven expression of the UAS-αSyn constructs prior to transfer to food supplemented or not with additional 15 mM or 30 mM CaCl2 for 1 or 2 weeks for Ca2+ pre-feeding at 25°C. Subsequently, flies were switched to food containing 10 mM MnCl2 (in 10% sucrose and 1% agar) and the number of dead flies was counted every 12 h. Fresh food was provided every second day. All lifespan experiments were repeated at least twice, and the depicted lifespans represent the total number of analyzed flies (exact numbers are indicated in the respective figure legends). In addition, flies were kept on food supplemented with either 15 mM CaCl2 or 15 mM MgCl2 as a control for two weeks at 25°C for determination of Cathepsin D activity. To assess climbing ability of flies, 6–8 flies were transferred into climbing vials without anesthesia to avoid confounding CO2 effects. Flies were allowed to adjust to red light for 20 min before measuring climbing activity. Flies were tapped down and climbing was recorded for 30 s. Three replicate runs were recorded per vial to determine mean climbing activity, and six independent experiments were performed per genotype. For evaluation, freeze images after 3 s of each run were generated, and the covered distance of each fly was analyzed using Fiji.
Confocal fluorescence microscopy
Subcellular localization of αSyn-GFP in living cells was assessed via confocal microscopy using a ZEISS LSM800 Airyscan microscope (Fig 1C), equipped with a Plan-Apochromat 63x/1.40 Oil M27 objective, and ZEISS ZEN software control. Micrographs in Figs 2B and 3E were recorded with a Leica SP5 confocal laser scanning microscope, equipped with a Leica HCX PL Apo 63x NA 1.4 oil immersion objective. Cells were counterstained with PI to visualize dead cells and subsequently immobilized on agar slides. Micrographs were processed with the open-source software Fiji [105]. Gaussian filtering (σ = 1) was applied to reduce image noise, followed by background subtraction (rolling ball radius = 50 pixels). Pictures within an experiment were captured and processed using the same settings.
Immunoblotting of yeast and fly lysates
Yeast whole cell extracts were generated using chemical lysis. Briefly, about 3x107 cells were collected, resuspended in 150 μl of 1.85 M NaOH/ 7.5% β-mercaptoethanol and incubated on ice for 10 min. Proteins were precipitated using 150 μl of 55% TCA and incubation on ice for 10 min. Subsequently, protein extracts were centrifuged for 10 min at 10000 g and 4°C, the supernatant was removed and the samples were resuspended in 150 μl urea loading buffer (200 mM Tris/HCl; 8 M urea; 5% SDS; 1 mM EDTA, 0.02% bromophenol blue; 15 mM DTT; pH 6.8) and incubated for 10 min at 65°C prior to loading on standard SDS-PAGE. Immunoblotting was performed using standard protocols with antibodies specific for FLAG-epitope (Sigma; F3165), yeast GAPDH (gift from Günther Daum, TU Graz), and GFP (Roche; #11814460001) and the respective peroxidase-conjugated affinity-purified secondary antibodies (Sigma).
To monitor αSyn dimers, about 8x107 cells were harvested 36 h after induction of galactose-driven expression, resuspended in 200 μl of 0.1 M NaOH and incubated at room temperature for 5 min, shaking with 1400 rpm. After centrifugation with 1500 g for 5 min, samples were resuspended in 150 μl non-reducing Lämmli buffer (50 mM Tris-HCl; 2% SDS; 10% glycerol; 0.1% bromophenol blue; pH 6.8) and again incubated at room temperature for 5 min with 1400 rpm shaking. After a final centrifugation step with 16000 g for 1 min, 10 μl of supernatant were loaded on polyacrylamide gels without SDS. Of note, electrophoresis was performed at 4°C, followed by immunoblotting using standard protocols and decoration with antibodies specific for αSyn (Sigma-Aldrich S3062) and tubulin (Abcam; ab184970). For detection, a ChemiDoc XRS+ (BioRad) was applied, followed by densitometric quantification with ImageLab v 5.2.1 Software (Bio-Rad).
All indicated molecular weights represent the apparent molecular weights (kDa) as determined with a PageRuler prestained protein ladder (Thermo Fisher Scientific) as stated by the manufacture’s migration patterns. For immunoblotting of Drosophila lysates, six fly heads per sample were collected and mechanically lysed in 24 μl fly lysis buffer (50 mM Tris/HCl, 150 mM NaCl, 1% Na-Deoxycholate, 0.1% Triton X-100, cOmplete Protease Inhibitor (Sigma); adjusted to pH 8.0). After centrifugation with 16000 g at 4°C for 10 min, 6 μl of 5 x Lämmli buffer (250 mM Tris/HCL; 20% SDS; 60% glycerol; adjusted to pH 6.8) were admixed to the supernatant and 15 μl of samples were applied for standard SDS-PAGE and immunoblotting. Blots were decorated with antibodies against αSyn (Sigma-Aldrich S3062) and Tubulin (Sigma-Aldrich T9026).
Total reflection X-ray fluorescence (TXRF) spectrometry
For whole cell multi-element analysis 6x107 cells were harvested by centrifugation (3 min, 3500 g), washed in 300 μl Milli-Q H2O, snap frozen in liquid nitrogen and stored at -20°C until further processing. Frozen cell pellets were resuspended in 100 μl 1% Triton X-100 at room temperature, mixed 1:1 with gallium standard solution (2 mg/l) and vortexed. 10 μl of sample were transferred to TXRF quartz glass carriers and carefully dried on a hot plate. Data collection was carried out for 1000 s on an S2 PICOFOX (automatic) spectrometer (Bruker Nano GmbH, Germany) equipped with a molybdenum excitation source (50 kV/600 μA). Elements were assigned manually and spectra quantified in the PICOFOX software. Spectra were recorded for n = 4 biological replicates per condition and values are represented as fold change to WT controls.
Cathepsin D activity assay
Measurement of Pep4/Cathepsin D activity was performed using a fluorometric Cathepsin D activity assay kit from Abcam (ab65302) according to the manufacturers protocol. For analysis of Pep4 activity in yeast, 2x106 cells were harvested 16 h after induction of galactose-driven expression of αSyn. Protein extracts were generated by mechanical lysis using glass beads and the supplied CD cell lysis buffer. For measurement of Cathepsin D activity in D. melanogaster, five fly heads per sample were collected at indicated time points and subsequently mechanically lysed in supplied CD cell lysis buffer. Protein concentration was determined via Bradford assay (Bio-Rad) and 0.1 μg protein was used for the Pep4/Cathepsin D activity assay. Reactions for yeast samples were incubated for 2 h at 28°C and fly samples for 2 h at 25°C. Fluorescence signal was measured with a Tecan Genios pro microplate reader (ex. 328 nm, em. 460 nm). Of note, lysates from Δpep4 yeast strains or wild type flies treated with 150 μM pepstatin A (dissolved in DMSO) were used as background control.
Determination of calcineurin activity
Calcineurin activity was determined using cells equipped with the reporter plasmid pAMS366-4xCDRE-GFPPEST, which codes for a destabilized GFP protein (yEGFPPEST) under the control of a calcineurin-dependent response element (CDRE) as previously described [56]. Briefly, about 2x105 yeast cells were harvested and stained with 100 ng/ml PI in PBS for 7 min. Cells were pelleted, resuspended in PBS and 3000 cells were analyzed using a Guava easyCyte 5HT flow cytometer. PI co-staining served to exclude dead cells from the analysis. Cells lacking Cnb1, the regulatory calcineurin subunit, served as control and obtained fluorescence intensities were subtracted as background.
Measurement of cytosolic calcium levels
Aequorin-based measurement of cytosolic calcium levels was performed as described earlier [26]. Briefly, the pEVP11/AEQ89 plasmid, coding for the bioluminescent reporter protein aequorin (kind gift from Kyle W. Cunningham) was transformed into yeast cells, which were cultivated as described above. At indicated time points, 1x108 cells were harvested in 96-well plates, resuspended in 200 μl SCD medium containing 4 μM coelenterazine h (ThermoFisher Scientific) and incubated for 1 h in the dark. To remove excess coelenterazine h, cells were washed once in SCD medium and incubated for 30 min. Luminescence signals were recorded in 0.5 s intervals for 25 s (basal Ca2+ levels) or 7 s + 80 s (response to external Ca2+ pulses) on a GloMax Multi Detection system (Promega). To follow the rapid cellular response to external Ca2+ addition, Ca2+ was automatically injected after 7 s to final concentrations of 10 mM or 50 mM. Values were normalized to OD600.
Statistical analyses
One-factor analysis of variance (ANOVA) corrected by a Tukey post-hoc test was used for all experiments with the following exceptions: A two-way ANOVA with time and strain as independent factors followed by a Tukey post-hoc test was applied to calculate differences in cytosolic Ca2+ levels over time (Fig 2F) and to compare αSyn toxicity in wild type and deletion mutants of the calcineurin pathway over time (Figs 1B and 3B). Statistical analysis for Drosophila survival was performed using Kaplan-Meier survival analysis and pairwise log rank comparisons were corrected via Bonferroni post-hoc test (Fig 6A, 6B, 6E and 6F). For climbing ability, a Kruskal-Wallis test was performed due to non-normally distributed data (Fig 6G).
Supporting information
(PDF)
(PDF)
(PDF)
(PDF)
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
Funding Statement
This work was supported by the Swedish Research Council Vetenskapsrådet (grants 2015-05468 and 2019-05249 to SB), Knut och Alice Wallenbergs Stiftelse (2017.0091 to SB), the Austrian Science Fund FWF (J4342-B21 to AA and P27183-B24 to SB), Stiftelsen Olle Engkvist Byggmästare (194-0681 to SB), and the Alfonso Martín Escudero foundation (to AO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Nussbaum RL, Polymeropoulos MH. Genetics of Parkinson’s disease. HumMolGenet. 1997;6: 1687–1691. doi: 10.1093/hmg/6.10.1687 [DOI] [PubMed] [Google Scholar]
- 2.Pang SY-Y, Ho PW-L, Liu H-F, Leung C-T, Li L, Chang EES, et al. The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease. Transl Neurodegener. 2019;8: 23. doi: 10.1186/s40035-019-0165-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388: 839–840. doi: 10.1038/42166 [DOI] [PubMed] [Google Scholar]
- 4.Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG, et al. Occupational exposures to metals as risk factors for Parkinson’s disease. Neurology. 1997;48: 650–658. doi: 10.1212/wnl.48.3.650 [DOI] [PubMed] [Google Scholar]
- 5.Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG, et al. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson’s disease. Neurotoxicology. 1999;20: 239–247. [PubMed] [Google Scholar]
- 6.Lucchini RG, Guazzetti S, Renzetti S, Broberg K, Caci M, Covolo L, et al. Metal Exposure and SNCA rs356219 Polymorphism Associated With Parkinson Disease and Parkinsonism. Front Neurol. 2020;11: 556337. doi: 10.3389/fneur.2020.556337 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Rybicki BA, Johnson CC, Uman J, Gorell JM. Parkinson’s disease mortality and the industrial use of heavy metals in Michigan. Mov Disord Off J Mov Disord Soc. 1993;8: 87–92. doi: 10.1002/mds.870080116 [DOI] [PubMed] [Google Scholar]
- 8.Barnham KJ, Bush AI. Metals in Alzheimer’s and Parkinson’s diseases. Curr Opin Chem Biol. 2008;12: 222–228. doi: 10.1016/j.cbpa.2008.02.019 [DOI] [PubMed] [Google Scholar]
- 9.Ijomone OM, Ifenatuoha CW, Aluko OM, Ijomone OK, Aschner M. The aging brain: impact of heavy metal neurotoxicity. Crit Rev Toxicol. 2020;50: 801–814. doi: 10.1080/10408444.2020.1838441 [DOI] [PubMed] [Google Scholar]
- 10.Mezzaroba L, Alfieri DF, Colado Simão AN, Vissoci Reiche EM. The role of zinc, copper, manganese and iron in neurodegenerative diseases. Neurotoxicology. 2019;74: 230–241. doi: 10.1016/j.neuro.2019.07.007 [DOI] [PubMed] [Google Scholar]
- 11.Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M, et al. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. AnnNeurol. 2004;55: 174–179. doi: 10.1002/ana.10846 [DOI] [PubMed] [Google Scholar]
- 12.Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease. NatGenet. 1998;18: 106–108. doi: 10.1038/ng0298-106 [DOI] [PubMed] [Google Scholar]
- 13.Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science. 1997;276: 2045–2047. doi: 10.1126/science.276.5321.2045 [DOI] [PubMed] [Google Scholar]
- 14.Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, et al. alpha-Synuclein locus triplication causes Parkinson’s disease. Science. 2003;302: 841. doi: 10.1126/science.1090278 [DOI] [PubMed] [Google Scholar]
- 15.Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. AnnNeurol. 2004;55: 164–173. doi: 10.1002/ana.10795 [DOI] [PubMed] [Google Scholar]
- 16.Harischandra DS, Rokad D, Neal ML, Ghaisas S, Manne S, Sarkar S, et al. Manganese promotes the aggregation and prion-like cell-to-cell exosomal transmission of α-synuclein. Sci Signal. 2019;12. doi: 10.1126/scisignal.aau4543 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Lorentzon E, Kumar R, Horvath I, Wittung-Stafshede P. Differential effects of Cu2+ and Fe3+ ions on in vitro amyloid formation of biologically-relevant α-synuclein variants. Biometals Int J Role Met Ions Biol Biochem Med. 2020;33: 97–106. doi: 10.1007/s10534-020-00234-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Moons R, Konijnenberg A, Mensch C, Van Elzen R, Johannessen C, Maudsley S, et al. Metal ions shape α-synuclein. Sci Rep. 2020;10: 16293. doi: 10.1038/s41598-020-73207-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Uversky VN, Li J, Fink AL. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson’s disease and heavy metal exposure. J Biol Chem. 2001;276: 44284–44296. doi: 10.1074/jbc.M105343200 [DOI] [PubMed] [Google Scholar]
- 20.Rcom-H’cheo-Gauthier AN, Osborne SL, Meedeniya ACB, Pountney DL. Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies. Front Neurosci. 2016;10: 570. doi: 10.3389/fnins.2016.00570 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Lautenschläger J, Stephens AD, Fusco G, Ströhl F, Curry N, Zacharopoulou M, et al. C-terminal calcium binding of α-synuclein modulates synaptic vesicle interaction. Nat Commun. 2018;9: 712. doi: 10.1038/s41467-018-03111-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Lowe R, Pountney DL, Jensen PH, Gai WP, Voelcker NH. Calcium(II) selectively induces alpha-synuclein annular oligomers via interaction with the C-terminal domain. Protein Sci Publ Protein Soc. 2004;13: 3245–3252. doi: 10.1110/ps.04879704 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Nath S, Goodwin J, Engelborghs Y, Pountney DL. Raised calcium promotes α-synuclein aggregate formation. Mol Cell Neurosci. 2011;46: 516–526. doi: 10.1016/j.mcn.2010.12.004 [DOI] [PubMed] [Google Scholar]
- 24.Rcom-H’cheo-Gauthier AN, Meedeniya ACB, Pountney DL. Calcipotriol inhibits α-synuclein aggregation in SH-SY5Y neuroblastoma cells by a Calbindin-D28k-dependent mechanism. J Neurochem. 2017;141: 263–274. doi: 10.1111/jnc.13971 [DOI] [PubMed] [Google Scholar]
- 25.Adamczyk A, Strosznajder JB. Alpha-synuclein potentiates Ca2+ influx through voltage-dependent Ca2+ channels. Neuroreport. 2006;17: 1883–1886. doi: 10.1097/WNR.0b013e3280115185 [DOI] [PubMed] [Google Scholar]
- 26.Büttner S, Faes L, Reichelt WN, Broeskamp F, Habernig L, Benke S, et al. The Ca2+/Mn2+ ion-pump PMR1 links elevation of cytosolic Ca(2+) levels to α-synuclein toxicity in Parkinson’s disease models. Cell Death Differ. 2013;20: 465–477. doi: 10.1038/cdd.2012.142 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Callewaert G, D’hooge P, Ma T-Y, Del Vecchio M, Van Eyck V, Franssens V, et al. Decreased Vacuolar Ca2+ Storage and Disrupted Vesicle Trafficking Underlie Alpha-Synuclein-Induced Ca2+ Dysregulation in S. cerevisiae. Front Genet. 2020;11: 266. doi: 10.3389/fgene.2020.00266 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, Giese A, et al. Different species of alpha-synuclein oligomers induce calcium influx and seeding. J Neurosci Off J Soc Neurosci. 2007;27: 9220–9232. doi: 10.1523/JNEUROSCI.2617-07.2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Hettiarachchi NT, Parker A, Dallas ML, Pennington K, Hung C-C, Pearson HA, et al. alpha-Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH-SY5Y) cells. J Neurochem. 2009;111: 1192–1201. doi: 10.1111/j.1471-4159.2009.06411.x [DOI] [PubMed] [Google Scholar]
- 30.Crocker SJ, Smith PD, Jackson-Lewis V, Lamba WR, Hayley SP, Grimm E, et al. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson’s disease. J Neurosci Off J Soc Neurosci. 2003;23: 4081–4091. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Mishizen-Eberz AJ, Norris EH, Giasson BI, Hodara R, Ischiropoulos H, Lee VM-Y, et al. Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein. Biochemistry. 2005;44: 7818–7829. doi: 10.1021/bi047846q [DOI] [PubMed] [Google Scholar]
- 32.Angelova PR, Ludtmann MHR, Horrocks MH, Negoda A, Cremades N, Klenerman D, et al. Ca2+ is a key factor in α-synuclein-induced neurotoxicity. J Cell Sci. 2016;129: 1792–1801. doi: 10.1242/jcs.180737 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Betzer C, Lassen LB, Olsen A, Kofoed RH, Reimer L, Gregersen E, et al. Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation. EMBO Rep. 2018;19: e44617. doi: 10.15252/embr.201744617 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Caraveo G, Auluck PK, Whitesell L, Chung CY, Baru V, Mosharov EV, et al. Calcineurin determines toxic versus beneficial responses to α-synuclein. Proc Natl Acad Sci U S A. 2014;111: E3544–3552. doi: 10.1073/pnas.1413201111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Lieberman OJ, Choi SJ, Kanter E, Saverchenko A, Frier MD, Fiore GM, et al. α-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian Neurotoxin. eNeuro. 2017;4. doi: 10.1523/ENEURO.0167-17.2017 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Boland B, Yu WH, Corti O, Mollereau B, Henriques A, Bezard E, et al. Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing. Nat Rev Drug Discov. 2018;17: 660–688. doi: 10.1038/nrd.2018.109 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Lynch-Day MA, Mao K, Wang K, Zhao M, Klionsky DJ. The role of autophagy in Parkinson’s disease. Cold Spring Harb Perspect Med. 2012;2: a009357. doi: 10.1101/cshperspect.a009357 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Manzoni C, Lewis PA. Dysfunction of the autophagy/lysosomal degradation pathway is a shared feature of the genetic synucleinopathies. FASEB J. 2013;27: 3424–3429. doi: 10.1096/fj.12-223842 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Tofaris GK. Lysosome-dependent pathways as a unifying theme in Parkinson’s disease. Mov Disord Off J Mov Disord Soc. 2012;27: 1364–1369. doi: 10.1002/mds.25136 [DOI] [PubMed] [Google Scholar]
- 40.Tsunemi T, Perez-Rosello T, Ishiguro Y, Yoroisaka A, Jeon S, Hamada K, et al. Increased Lysosomal Exocytosis Induced by Lysosomal Ca2+ Channel Agonists Protects Human Dopaminergic Neurons from α-Synuclein Toxicity. J Neurosci Off J Soc Neurosci. 2019;39: 5760–5772. doi: 10.1523/JNEUROSCI.3085-18.2019 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Büttner S, Habernig L, Broeskamp F, Ruli D, Vögtle FN, Vlachos M, et al. Endonuclease G mediates α-synuclein cytotoxicity during Parkinson’s disease. EMBO J. 2013;32: 3041–3054. doi: 10.1038/emboj.2013.228 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B, et al. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson’s models. Science. 2006;313: 324–328. doi: 10.1126/science.1129462 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Feany MB, Bender WW. A Drosophila model of Parkinson’s disease. Nature. 2000;404: 394–398. doi: 10.1038/35006074 [DOI] [PubMed] [Google Scholar]
- 44.Gitler AD, Chesi A, Geddie ML, Strathearn KE, Hamamichi S, Hill KJ, et al. Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet. 2009;41: 308–315. doi: 10.1038/ng.300 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Outeiro TF, Lindquist S. Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science. 2003;302: 1772–1775. doi: 10.1126/science.1090439 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Bagur R, Hajnóczky G. Intracellular Ca2+ Sensing: Its Role in Calcium Homeostasis and Signaling. Mol Cell. 2017;66: 780–788. doi: 10.1016/j.molcel.2017.05.028 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Cui J, Kaandorp JA, Sloot PMA, Lloyd CM, Filatov MV. Calcium homeostasis and signaling in yeast cells and cardiac myocytes. FEMS Yeast Res. 2009;9: 1137–1147. doi: 10.1111/j.1567-1364.2009.00552.x [DOI] [PubMed] [Google Scholar]
- 48.Cyert MS, Philpott CC. Regulation of cation balance in Saccharomyces cerevisiae. Genetics. 2013;193: 677–713. doi: 10.1534/genetics.112.147207 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Binolfi A, Rasia RM, Bertoncini CW, Ceolin M, Zweckstetter M, Griesinger C, et al. Interaction of alpha-synuclein with divalent metal ions reveals key differences: a link between structure, binding specificity and fibrillation enhancement. J Am Chem Soc. 2006;128: 9893–9901. doi: 10.1021/ja0618649 [DOI] [PubMed] [Google Scholar]
- 50.Choi TS, Lee J, Han JY, Jung BC, Wongkongkathep P, Loo JA, et al. Supramolecular Modulation of Structural Polymorphism in Pathogenic α-Synuclein Fibrils Using Copper(II) Coordination. Angew Chem Int Ed. 2018;57: 3099–3103. doi: 10.1002/anie.201712286 [DOI] [PubMed] [Google Scholar]
- 51.Santner A, Uversky VN. Metalloproteomics and metal toxicology of α-synuclein. Met Integr Biometal Sci. 2010;2: 378–392. doi: 10.1039/b926659c [DOI] [PubMed] [Google Scholar]
- 52.Wright JA, Brown DR. Alpha-synuclein and its role in metal binding: relevance to Parkinson’s disease. J Neurosci Res. 2008;86: 496–503. doi: 10.1002/jnr.21461 [DOI] [PubMed] [Google Scholar]
- 53.Follett J, Darlow B, Wong MB, Goodwin J, Pountney DL. Potassium depolarization and raised calcium induces α-synuclein aggregates. Neurotox Res. 2013;23: 378–392. doi: 10.1007/s12640-012-9366-z [DOI] [PubMed] [Google Scholar]
- 54.Han JY, Choi TS, Kim HI. Molecular Role of Ca2+ and Hard Divalent Metal Cations on Accelerated Fibrillation and Interfibrillar Aggregation of α-Synuclein. Sci Rep. 2018;8: 1895. doi: 10.1038/s41598-018-20320-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Connolly S, Kingsbury T. Regulatory Subunit Myristoylation Antagonizes Calcineurin Phosphatase Activation in Yeast. J Biol Chem. 2012;287: 39361–39368. doi: 10.1074/jbc.M112.366617 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Diessl J, Nandy A, Schug C, Habernig L, Büttner S. Stable and destabilized GFP reporters to monitor calcineurin activity in Saccharomyces cerevisiae. Microb Cell Graz Austria. 2020;7: 106–114. doi: 10.15698/mic2020.04.713 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol. 2000;1: 11–21. doi: 10.1038/35036035 [DOI] [PubMed] [Google Scholar]
- 58.Matheos DP, Kingsbury TJ, Ahsan US, Cunningham KW. Tcn1p/Crz1p, a calcineurin-dependent transcription factor that differentially regulates gene expression in Saccharomyces cerevisiae. Genes Dev. 1997;11: 3445–3458. doi: 10.1101/gad.11.24.3445 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Stathopoulos-Gerontides A, Guo JJ, Cyert MS. Yeast calcineurin regulates nuclear localization of the Crz1p transcription factor through dephosphorylation. Genes Dev. 1999;13: 798–803. doi: 10.1101/gad.13.7.798 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Goldman A, Roy J, Bodenmiller B, Wanka S, Landry CR, Aebersold R, et al. The calcineurin signaling network evolves via conserved kinase-phosphatase modules that transcend substrate identity. Mol Cell. 2014;55: 422–435. doi: 10.1016/j.molcel.2014.05.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Piña FJ, O’Donnell AF, Pagant S, Piao HL, Miller JP, Fields S, et al. Hph1 and Hph2 are novel components of the Sec63/Sec62 posttranslational translocation complex that aid in vacuolar proton ATPase biogenesis. Eukaryot Cell. 2011;10: 63–71. doi: 10.1128/EC.00241-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Spedale G, Mischerikow N, Heck AJR, Timmers HTM, Pijnappel WWMP. Identification of Pep4p as the protease responsible for formation of the SAGA-related SLIK protein complex. J Biol Chem. 2010;285: 22793–22799. doi: 10.1074/jbc.M110.108787 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Kerstens W, Dijck PV. A Cinderella story: how the vacuolar proteases Pep4 and Prb1 do more than cleaning up the cell’s mass degradation processes. Microb Cell. 2018;5: 438–443. doi: 10.15698/mic2018.10.650 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.D’hooge P, Coun C, Van Eyck V, Faes L, Ghillebert R, Mariën L, et al. Ca(2+) homeostasis in the budding yeast Saccharomyces cerevisiae: Impact of ER/Golgi Ca(2+) storage. Cell Calcium. 2015;58: 226–235. doi: 10.1016/j.ceca.2015.05.004 [DOI] [PubMed] [Google Scholar]
- 65.Strayle J, Pozzan T, Rudolph HK. Steady-state free Ca(2+) in the yeast endoplasmic reticulum reaches only 10 microM and is mainly controlled by the secretory pathway pump pmr1. EMBO J. 1999;18: 4733–4743. doi: 10.1093/emboj/18.17.4733 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Aufschnaiter A, Habernig L, Kohler V, Diessl J, Carmona-Gutierrez D, Eisenberg T, et al. The Coordinated Action of Calcineurin and Cathepsin D Protects Against α-Synuclein Toxicity. Front Mol Neurosci. 2017;10: 207. doi: 10.3389/fnmol.2017.00207 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Uribe S, Rangel P, Pardo JP. Interactions of calcium with yeast mitochondria. Cell Calcium. 1992;13: 211–217. doi: 10.1016/0143-4160(92)90009-h [DOI] [PubMed] [Google Scholar]
- 68.Kovács-Bogdán E, Sancak Y, Kamer KJ, Plovanich M, Jambhekar A, Huber RJ, et al. Reconstitution of the mitochondrial calcium uniporter in yeast. Proc Natl Acad Sci U S A. 2014;111: 8985–8990. doi: 10.1073/pnas.1400514111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Zulkifli M, Neff JK, Timbalia SA, Garza NM, Chen Y, Watrous JD, et al. Yeast homologs of human MCUR1 regulate mitochondrial proline metabolism. Nat Commun. 2020;11: 4866. doi: 10.1038/s41467-020-18704-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Halachmi D, Eilam Y. Elevated cytosolic free Ca2+ concentrations and massive Ca2+ accumulation within vacuoles, in yeast mutant lacking PMR1, a homolog of Ca2+ -ATPase. FEBS Lett. 1996;392: 194–200. doi: 10.1016/0014-5793(96)00799-5 [DOI] [PubMed] [Google Scholar]
- 71.Cunningham KW, Fink GR. Calcineurin inhibits VCX1-dependent H+/Ca2+ exchange and induces Ca2+ ATPases in Saccharomyces cerevisiae. Mol Cell Biol. 1996;16: 2226–2237. doi: 10.1128/MCB.16.5.2226 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Matrone C, Dzamko N, Madsen P, Nyegaard M, Pohlmann R, Søndergaard RV, et al. Mannose 6-Phosphate Receptor Is Reduced in -Synuclein Overexpressing Models of Parkinsons Disease. PloS One. 2016;11: e0160501. doi: 10.1371/journal.pone.0160501 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Sevlever D, Jiang P, Yen S-HC. Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species. Biochemistry. 2008;47: 9678–9687. doi: 10.1021/bi800699v [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Qiao L, Hamamichi S, Caldwell KA, Caldwell GA, Yacoubian TA, Wilson S, et al. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. MolBrain. 2008;1: 17. doi: 10.1186/1756-6606-1-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Zimprich A, Benet-Pagès A, Struhal W, Graf E, Eck SH, Offman MN, et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am J Hum Genet. 2011;89: 168–175. doi: 10.1016/j.ajhg.2011.06.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.McMillan KJ, Gallon M, Jellett AP, Clairfeuille T, Tilley FC, McGough I, et al. Atypical parkinsonism-associated retromer mutant alters endosomal sorting of specific cargo proteins. J Cell Biol. 2016;214: 389–399. doi: 10.1083/jcb.201604057 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Williams ET, Chen X, Moore DJ. VPS35, the Retromer Complex and Parkinson’s Disease. J Park Dis. 2017;7: 219–233. doi: 10.3233/JPD-161020 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Aufschnaiter A, Kohler V, Büttner S. Taking out the garbage: cathepsin D and calcineurin in neurodegeneration. Neural Regen Res. 2017;12: 1776–1779. doi: 10.4103/1673-5374.219031 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Follett J, Norwood SJ, Hamilton NA, Mohan M, Kovtun O, Tay S, et al. The Vps35 D620N mutation linked to Parkinson’s disease disrupts the cargo sorting function of retromer. Traffic Cph Den. 2014;15: 230–244. doi: 10.1111/tra.12136 [DOI] [PubMed] [Google Scholar]
- 80.Kweon Y, Rothe A, Conibear E, Stevens TH. Ykt6p is a multifunctional yeast R-SNARE that is required for multiple membrane transport pathways to the vacuole. Mol Biol Cell. 2003;14: 1868–1881. doi: 10.1091/mbc.e02-10-0687 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.McGrath K, Agarwal S, Tonelli M, Dergai M, Gaeta AL, Shum AK, et al. A conformational switch driven by phosphorylation regulates the activity of the evolutionarily conserved SNARE Ykt6. Proc Natl Acad Sci U S A. 2021;118: e2016730118. doi: 10.1073/pnas.2016730118 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Sakata N, Shirakawa R, Goto K, Trinh DA, Horiuchi H. Double prenylation of SNARE protein Ykt6 is required for lysosomal hydrolase trafficking. J Biochem (Tokyo). 2021;169: 363–370. doi: 10.1093/jb/mvaa111 [DOI] [PubMed] [Google Scholar]
- 83.Foster TC, Sharrow KM, Masse JR, Norris CM, Kumar A. Calcineurin Links Ca2+ Dysregulation with Brain Aging. J Neurosci. 2001;21: 4066–4073. doi: 10.1523/JNEUROSCI.21-11-04066.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Graef IA, Wang F, Charron F, Chen L, Neilson J, Tessier-Lavigne M, et al. Neurotrophins and netrins require calcineurin/NFAT signaling to stimulate outgrowth of embryonic axons. Cell. 2003;113: 657–670. doi: 10.1016/s0092-8674(03)00390-8 [DOI] [PubMed] [Google Scholar]
- 85.Sklar EM. Post-transplant Neurotoxicity: What Role do Calcineurin Inhibitors Actually Play? Am J Neuroradiol. 2006;27: 1602–1603. [PMC free article] [PubMed] [Google Scholar]
- 86.Wu H-Y, Tomizawa K, Oda Y, Wei F-Y, Lu Y-F, Matsushita M, et al. Critical Role of Calpain-mediated Cleavage of Calcineurin in Excitotoxic Neurodegeneration. J Biol Chem. 2004;279: 4929–4940. doi: 10.1074/jbc.M309767200 [DOI] [PubMed] [Google Scholar]
- 87.Zeng H, Chattarji S, Barbarosie M, Rondi-Reig L, Philpot BD, Miyakawa T, et al. Forebrain-Specific Calcineurin Knockout Selectively Impairs Bidirectional Synaptic Plasticity and Working/Episodic-like Memory. Cell. 2001;107: 617–629. doi: 10.1016/s0092-8674(01)00585-2 [DOI] [PubMed] [Google Scholar]
- 88.Shi X, Sun Y, Wang P, Gu L, Wang L, Yang H, et al. The interaction between calcineurin and α-synuclein is regulated by calcium and calmodulin. Biochem Biophys Res Commun. 2018;496: 1109–1114. doi: 10.1016/j.bbrc.2018.01.148 [DOI] [PubMed] [Google Scholar]
- 89.Calì T, Ottolini D, Brini M. Calcium signaling in Parkinson’s disease. Cell Tissue Res. 2014;357: 439–454. doi: 10.1007/s00441-014-1866-0 [DOI] [PubMed] [Google Scholar]
- 90.Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick C, Tkatch T, et al. “Rejuvenation” protects neurons in mouse models of Parkinson’s disease. Nature. 2007;447: 1081–1086. doi: 10.1038/nature05865 [DOI] [PubMed] [Google Scholar]
- 91.Surmeier DJ, Guzman JN, Sanchez-Padilla J. Calcium, cellular aging, and selective neuronal vulnerability in Parkinson’s disease. Cell Calcium. 2010;47: 175–182. doi: 10.1016/j.ceca.2009.12.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Striessnig J, Koschak A, Sinnegger-Brauns MJ, Hetzenauer A, Nguyen NK, Busquet P, et al. Role of voltage-gated L-type Ca2+ channel isoforms for brain function. Biochem Soc Trans. 2006;34: 903–909. doi: 10.1042/BST0340903 [DOI] [PubMed] [Google Scholar]
- 93.Wilson CJ, Callaway JC. Coupled oscillator model of the dopaminergic neuron of the substantia nigra. J Neurophysiol. 2000;83: 3084–3100. doi: 10.1152/jn.2000.83.5.3084 [DOI] [PubMed] [Google Scholar]
- 94.Guzman JN, Sanchez-Padilla J, Wokosin D, Kondapalli J, Ilijic E, Schumacker PT, et al. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature. 2010;468: 696–700. doi: 10.1038/nature09536 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Ilijic E, Guzman J, Surmeier D. The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson’s disease. Neurobiol Dis. 2011;43: 364–371. doi: 10.1016/j.nbd.2011.04.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Parkinson Study Group STEADY-PD III Investigators. Isradipine Versus Placebo in Early Parkinson Disease: A Randomized Trial. Ann Intern Med. 2020;172: 591–598. doi: 10.7326/M19-2534 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Abou-Raya S, Helmii M, Abou-Raya A. Bone and mineral metabolism in older adults with Parkinson’s disease. Age Ageing. 2009;38: 675–680. doi: 10.1093/ageing/afp137 [DOI] [PubMed] [Google Scholar]
- 98.Harischandra DS, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson’s disease. Toxicol Sci Off J Soc Toxicol. 2015;143: 454–468. doi: 10.1093/toxsci/kfu247 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Yan D-Y, Liu C, Tan X, Ma Z, Wang C, Deng Y, et al. Mn- Induced Neurocytes Injury and Autophagy Dysfunction in Alpha-Synuclein Wild-Type and Knock-Out Mice: Highlighting the Role of Alpha-Synuclein. Neurotox Res. 2019;36: 66–80. doi: 10.1007/s12640-019-00016-y [DOI] [PubMed] [Google Scholar]
- 100.Bornhorst J, Chakraborty S, Meyer S, Lohren H, Brinkhaus SG, Knight AL, et al. The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans. Met Integr Biometal Sci. 2014;6: 476–490. doi: 10.1039/c3mt00325f [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Gietz RD, Woods RA. Transformation of yeast by lithium acetate/single-stranded carrier DNA/polyethylene glycol method. Methods Enzymol. 2002;350: 87–96. doi: 10.1016/s0076-6879(02)50957-5 [DOI] [PubMed] [Google Scholar]
- 102.Büttner S, Bitto A, Ring J, Augsten M, Zabrocki P, Eisenberg T, et al. Functional mitochondria are required for alpha-synuclein toxicity in aging yeast. JBiolChem. 2008;283: 7554–7560. doi: 10.1074/jbc.M708477200 [DOI] [PubMed] [Google Scholar]
- 103.Janke C, Magiera MM, Rathfelder N, Taxis C, Reber S, Maekawa H, et al. A versatile toolbox for PCR-based tagging of yeast genes: new fluorescent proteins, more markers and promoter substitution cassettes. Yeast Chichester Engl. 2004;21: 947–962. doi: 10.1002/yea.1142 [DOI] [PubMed] [Google Scholar]
- 104.Herker E, Jungwirth H, Lehmann KA, Maldener C, Frohlich KU, Wissing S, et al. Chronological aging leads to apoptosis in yeast. JCell Biol. 2004;164: 501–507. doi: 10.1083/jcb.200310014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9: 676–682. doi: 10.1038/nmeth.2019 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
(PDF)
(PDF)
(PDF)
(PDF)
Data Availability Statement
All relevant data are within the manuscript and its Supporting Information files.